|
Company:
|
MARIZYME INC (MRZM)
|
|
Form Type:
|
8-K/A
|
|
Filing Date:
|
6/6/2011
|
|
CIK:
|
0001413754
|
|
Address:
|
555 HERITAGE DRIVE
SUITE 205
|
|
City, State, Zip:
|
JUPITER, Florida 33458
|
|
Telephone:
|
561-935-9955
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$1.00
|
Change:
-0.15 (-13.04%)
|
Trade Time:
Jul 30
|
Market Cap:
$35.93M
|
|
|
|
|
|
|
Description of Business
|
|
We are a Nevada corporation originally incorporated on March 20, 2007, under the
name SWAV Enterprises, Ltd. On September 6, 2010, we changed our name to GBS
Enterprises Incorporated and from 2010 to September 2018 we were in the software
products and advisory services business for email and instant messaging
applications. We divested that business between December 2016 and September 2018
and, since that time, we have begun to focus on the acquisition of life science
technologies.
We changed our name to Marizyme, Inc. on March 21, 2018, to reflect our new life
sciences focus. Our common stock is currently quoted on the OTC Markets' QB tier
under the symbol "MRZM." We may also examine our options with respect to the
listing of our common stock on the Nasdaq Stock market or the NYSE.
In the second half of 2018, we acquired the protease-based therapeutic platform
called Krillase® from ACB Holding AB.
|
|
|
|